진원생명과학 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 동반성장투자조합제1호, was filed 09 Mar 2026.
진원생명과학: what insiders have been doing
Every trade that managers of 진원생명과학 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. In the past year (1 November 2025 to 1 November 2026), 18 filings came from 5 insiders.
The record shows 1 purchase on the open market, made by 1 insider, against 10 sales by 4 insiders. The totals do not cover 11 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
With 18 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Our records for 진원생명과학 go back to 2021, with 1 purchase and 22 sales on the open market in total.
The last purchase on record was published on 9 March 2026, which is 246 days ago. Filings reach the DART (FSS) feed a median of 4 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +0.2%Entry ₩1,099 · Close at T+90 ₩1,101
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 4,096 sharesShareKRXDART:20260629000401
- 9,010,743 sharesKRXDART:20260629000390
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 64,500 sharesShareKRXDART:20260330001275
- ●Executives0DART
- 4,104,358 sharesKRXDART:20260309001281Canonical exit: 3 Jun 2026 (T+90)
- 1,163,843 sharesKRXDART:20260213000287
- 743,915 sharesKRXDART:20260213000162
- 140,363 sharesKRXDART:20260206000084
- 1,464,122 sharesKRXDART:20260206000067
- 701,710 sharesKRXDART:20260206001495
- 0KRXDART:20260206000091
- 743,915 sharesKRXDART:20260127000168
- 743,915 sharesKRXDART:20260126000416
- ●Executives0DART
- 64,675 sharesShareKRXDART:20250502000142
- 64,675 shares@ ₩2,270.00100.0% of flowShareKRXDART:20250430000652
- 743,915 sharesKRXDART:20250430000638
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 66 declarations
About 진원생명과학
Jinwon Life Sciences is a biotechnology company focused on developing treatments for infectious diseases and cancers. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
